SecBot SecBot
PRESS-RELEASE ·Filed Mar 2, 2026

IVVD

Invivyd
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

Traders should monitor the upcoming earnings call for any material updates on financial performance, pipeline progress, or commercialization of the FDA EUA-authorized monoclonal antibody.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.62
T+0 close · Mar 2, 2026 · via day close
Latest settled
−30.25%
T+60 · $1.13
Vs SPY
−40.56%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 3 $1.62entry
  2. T+1 · 9mo ago +5.56%α +4.79% · $1.71
  3. T+5 · 8mo ago +12.96%α +13.44% · $1.83
  4. T+20 · 8mo ago −19.75%α −15.35% · $1.30
  5. T+60 · 6mo ago −30.25%α −40.56% · $1.13
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Invivyd announced it will host a conference call on March 5, 2026, to discuss its Q4 and full-year 2025 financial results and provide a corporate update. The press release contains no financial data or material operational updates, serving only as a notification of the upcoming earnings event.

Key Facts

  • Invivyd will host a conference call on March 5, 2026, at 8:30 a.m. ET.
  • The call will cover Q4 and full-year 2025 financial results and a corporate update.
  • No financial figures, guidance, or operational results were disclosed in the release.
  • A webcast and replay will be available via the company’s investor relations website.

Financial Impact

No financial data disclosed

Risk Factors

  • Lack of disclosed financials increases uncertainty ahead of the earnings call.
  • Biotech stocks like IVVD can be volatile around earnings and regulatory updates.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3247875

Track record

19 reports on IVVD

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +35.85% at T+20 after the Jul 6, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Neutral 6/10 Entry $0.5603 Now $0.5380 −3.98% settles Nov 23
  2. Nov 3, 202613d ago Press Release Neutral 2/10 Entry $0.5815 to $0.5744 Now $0.5380 −7.48% ▼ −1.22% −0.63% vs SPY
  3. Sep 29, 20266w ago 8-K Bullish 7/10 Entry $0.8501 to $0.8064 Now $0.5380 −36.71% ▼ −5.14% −7.09% vs SPY
  4. Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $0.9640 to $0.8501 Now $0.5380 −44.19% ▼ −11.82% −10.63% vs SPY
  5. Sep 1, 202610w ago 8-K Neutral 6/10 Entry $0.8800 to $0.7973 Now $0.5380 −38.86% ▼ −9.40% −9.48% vs SPY
  6. Aug 17, 202613w ago 144 Neutral 2/10 Entry $0.8680 to $0.9387 Now $0.5380 −38.02% ▲ +8.15% +8.35% vs SPY
  7. Jul 6, 202619w ago 8-K Bearish 6/10 Entry $0.8340 to $0.7834 Now $0.5380 +35.49% ▲ +6.07% +6.56% vs SPY
  8. Jun 16, 202621w ago Press Release Neutral 5/10 Entry $0.8918 to $0.9346 Now $0.5380 −39.67% ▲ +4.80% +7.03% vs SPY
  9. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $0.8125 to $0.9312 Now $0.5380 −33.78% ▲ +14.61% +14.18% vs SPY
  10. Jun 9, 202622w ago Press Release Neutral 4/10 Entry $0.9900 to $0.8686 Now $0.5380 −45.66% ▼ −12.26% −14.67% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 6h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 2, 2026